Granules India Limited Share Price & Analysis
₹705.25▲ +0.01%Updated 29 Apr 2026, 11:32 am IST
LTP
₹705.25
+0.01%
Open
₹—
High
₹718.7
Low
₹704.65
Close
₹705.25
52W High
₹696
52W Low
₹431
Volume
385K
Lot Size
1
Sector
Healthcare
Market Cap
₹17K Cr
Face Value
₹1
Mid CapNIFTY 500
Price Chart
Fundamentals
P/E
31.4
Sector P/E
41.5
P/B
4.3
EPS
₹22.48
ROE
13.9%
ROCE
15.1%
D/E Ratio
0.45
Div Yield
0.22%
Book Value
₹164
+
Strengths
- ✓Efficient capital deployment (ROCE 15.1%)
- ✓Attractively valued vs sector (P/E 31.4x vs industry 41.5x)
- ✓Low debt relative to equity (D/E 0.5x)
−
Concerns
- ✗Trading near 52-week high (₹696)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,756 | ₹3.9L Cr | 32 | 5.42 | 16.9 | 20.2 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,482 | ₹1.7L Cr | 66.7 | 11.16 | 15.4 | 20.4 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,265 | ₹1.4L Cr | 60.4 | 17.06 | 26.5 | 27 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹7,767 | ₹1.1L Cr | 61.2 | 12.29 | 18.4 | 16.6 | 0.88 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,345 | ₹1.1L Cr | 19.7 | 3.11 | 18 | 22.7 | 0.16 |
| LUPIN Lupin Limited | ₹2,317 | ₹1.0L Cr | 21.1 | 5.39 | 20.6 | 21.3 | 0.32 |
| CIPLA Cipla Limited | ₹1,319 | ₹1.0L Cr | 22 | 3.23 | 17.8 | 22.7 | 0.01 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
GRANULES · as of Mar 2026
Promoters38.83%▼0.02
FII15.14%▼0.73
DII22.45%▲2.88
Public23.56%▼2.15
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 41.97% | 41.96% | 38.87% | 38.87% | 38.85% | 38.83% |
| FII | 18.78% | 19.57% | 20.39% | 19.49% | 15.87% | 15.14% |
| DII | 10.16% | 10.70% | 14.11% | 14.85% | 19.57% | 22.45% |
| Public | 29.10% | 27.77% | 26.61% | 26.80% | 25.71% | 23.56% |
Corporate Events
To consider and approve the financial results for the period ended March 31, 2026 and dividend
Dividend28 Apr 2026
Dividend - Rs 1.50 Per Share
Dividend30 Jul 2025
Annual General Meeting/Dividend - Rs 1.50 Per Share
Dividend29 Jul 2024
Annual General Meeting
AGM2 Aug 2023
Dividend - Rs 1.50 Per Share
Dividend2 Aug 2023
Latest News
All news →Granules India Hyderabad facility receives 5 USFDA observations
*Granules India arm gets 5 USFDA observations for Hyderabad facility.* The pharma company's subsidiary received **5 observations** from the US FDA during inspection of its Hyderabad manufacturing facility. These observations typically require corrective action plans but are not critical deficiencies. The company will need to address these compliance issues to maintain its US market certifications. 📊 *STOCKS:* GRANULES | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Compliance
Medical Dialogues2d ago
Granules India Virginia facility receives FDA EIR approval
*Granules India's Virginia manufacturing facility has received an Establishment Inspection Report (EIR) from the US FDA.* This approval allows the facility to operate without significant compliance issues and supports the company's API exports to the US market. The EIR is a positive regulatory milestone for the pharma manufacturer's operations. 📊 *STOCKS:* $GRANULES | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #FDA #Regulatory
Medical Dialogues2d ago
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.4K Cr ▲7.0% | ₹1.3K Cr ▲7.2% | ₹1.2K Cr ▲1.1% | ₹1.2K Cr ▲5.2% | ₹1.1K Cr ▲17.7% | ₹967 Cr ▼18.1% | ₹1.2K Cr ▲0.3% | ₹1.2K Cr |
| Op. Profit | ₹308 Cr ▲10.8% | ₹278 Cr ▲12.6% | ₹247 Cr ▼2.0% | ₹252 Cr ▲9.6% | ₹230 Cr ▲13.3% | ₹203 Cr ▼21.6% | ₹259 Cr ▲1.2% | ₹256 Cr |
| OPM | 22.0% ▲4.8% | 21.0% ▲5.0% | 20.0% ▼4.8% | 21.0% ▲5.0% | 20.0% ▼4.8% | 21.0% ▼4.5% | 22.0% ▲0.0% | 22.0% |
| Net Profit | ₹150 Cr ▲14.5% | ₹131 Cr ▲15.9% | ₹113 Cr ▼25.7% | ₹152 Cr ▲28.8% | ₹118 Cr ▲21.6% | ₹97 Cr ▼28.1% | ₹135 Cr ▲3.8% | ₹130 Cr |
| EPS (₹) | 6.19 ▲15.1% | 5.38 ▲15.9% | 4.64 ▼26.0% | 6.27 ▲29.3% | 4.85 ▲20.9% | 4.01 ▼27.9% | 5.56 ▲3.9% | 5.35 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹4.5K Cr ▼0.5% | ₹4.5K Cr ▼0.1% | ₹4.5K Cr ▲19.8% | ₹3.8K Cr ▲16.3% | ₹3.2K Cr ▲24.6% | ₹2.6K Cr ▲14.0% | ₹2.3K Cr ▲35.3% | ₹1.7K Cr ▲19.4% | ₹1.4K Cr |
| Expenses | ₹3.5K Cr ▼3.1% | ₹3.6K Cr ▲1.4% | ₹3.6K Cr ▲18.4% | ₹3.0K Cr ▲27.5% | ₹2.4K Cr ▲14.9% | ₹2.1K Cr ▲9.4% | ₹1.9K Cr ▲34.8% | ₹1.4K Cr ▲26.4% | ₹1.1K Cr |
| Op. Profit | ₹948 Cr ▲10.5% | ₹858 Cr ▼6.2% | ₹915 Cr ▲25.9% | ₹727 Cr ▼15.1% | ₹856 Cr ▲62.7% | ₹526 Cr ▲37.0% | ₹384 Cr ▲38.1% | ₹278 Cr ▼7.0% | ₹299 Cr |
| OPM | 21.0% ▲10.5% | 19.0% ▼5.0% | 20.0% ▲5.3% | 19.0% ▼26.9% | 26.0% ▲30.0% | 20.0% ▲17.6% | 17.0% ▲0.0% | 17.0% ▼19.0% | 21.0% |
| Other Income | ₹41 Cr ▲1950.0% | ₹2 Cr ▼83.3% | ₹12 Cr ▼7.7% | ₹13 Cr ▼50.0% | ₹26 Cr ▼71.1% | ₹90 Cr ▲20.0% | ₹75 Cr ▲177.8% | ₹27 Cr ▼22.9% | ₹35 Cr |
| Interest | ₹103 Cr ▼2.8% | ₹106 Cr ▲89.3% | ₹56 Cr ▲143.5% | ₹23 Cr ▼11.5% | ₹26 Cr ▼3.7% | ₹27 Cr ▼3.6% | ₹28 Cr ▼15.2% | ₹33 Cr ▲3.1% | ₹32 Cr |
| Depreciation | ₹226 Cr ▲9.2% | ₹207 Cr ▲12.5% | ₹184 Cr ▲15.7% | ₹159 Cr ▲5.3% | ₹151 Cr ▲10.2% | ₹137 Cr ▲30.5% | ₹105 Cr ▲38.2% | ₹76 Cr ▲5.6% | ₹72 Cr |
| PBT | ₹660 Cr ▲20.7% | ₹547 Cr ▼20.4% | ₹687 Cr ▲23.1% | ₹558 Cr ▼20.7% | ₹704 Cr ▲56.1% | ₹451 Cr ▲38.3% | ₹326 Cr ▲66.3% | ₹196 Cr ▼14.8% | ₹230 Cr |
| Tax % | 24.0% ▼7.7% | 26.0% ▲4.0% | 25.0% ▼3.8% | 26.0% ▲18.2% | 22.0% ▼15.4% | 26.0% ▼3.7% | 27.0% ▼15.6% | 32.0% ▲14.3% | 28.0% |
| Net Profit | ₹502 Cr ▲24.0% | ₹405 Cr ▼21.7% | ₹517 Cr ▲25.2% | ₹413 Cr ▼24.8% | ₹549 Cr ▲63.9% | ₹335 Cr ▲41.9% | ₹236 Cr ▲77.4% | ₹133 Cr ▼19.4% | ₹165 Cr |
| EPS (₹) | 20.68 ▲23.7% | 16.72 ▼21.6% | 21.34 ▲28.2% | 16.64 ▼25.0% | 22.18 ▲68.2% | 13.19 ▲41.8% | 9.3 ▲78.2% | 5.22 ▼27.4% | 7.19 |
| Div Payout | 7.0% ▼22.2% | 9.0% ▲28.6% | 7.0% ▼22.2% | 9.0% ▲28.6% | 7.0% ▼12.5% | 8.0% ▼27.3% | 11.0% ▼42.1% | 19.0% ▲46.2% | 13.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹24 Cr ▲0.0% | ₹24 Cr ▲0.0% | ₹24 Cr ▲0.0% | ₹24 Cr ▼4.0% | ₹25 Cr ▲0.0% | ₹25 Cr ▲0.0% | ₹25 Cr ▲0.0% | ₹25 Cr ▲0.0% | ₹25 Cr ▲8.7% | ₹23 Cr |
| Reserves | ₹4.0K Cr ▲7.3% | ₹3.7K Cr ▲15.3% | ₹3.2K Cr ▲13.9% | ₹2.8K Cr ▲9.7% | ₹2.6K Cr ▲19.2% | ₹2.1K Cr ▲18.2% | ₹1.8K Cr ▲20.9% | ₹1.5K Cr ▲17.6% | ₹1.3K Cr ▲45.2% | ₹881 Cr |
| Borrowings | ₹1.8K Cr ▲24.2% | ₹1.5K Cr ▲10.6% | ₹1.3K Cr ▲15.8% | ₹1.1K Cr ▲2.7% | ₹1.1K Cr ▲30.3% | ₹849 Cr ▼4.8% | ₹892 Cr ▼10.0% | ₹991 Cr ▲1.3% | ₹978 Cr ▲49.1% | ₹656 Cr |
| Other Liabilities | ₹1.2K Cr ▲9.8% | ₹1.1K Cr ▲9.8% | ₹957 Cr ▲2.7% | ₹932 Cr ▲13.8% | ₹819 Cr ▲18.7% | ₹690 Cr ▲41.7% | ₹487 Cr ▲6.3% | ₹458 Cr ▲18.0% | ₹388 Cr ▲21.6% | ₹319 Cr |
| Total Liabilities | ₹6.9K Cr ▲11.6% | ₹6.2K Cr ▲13.2% | ₹5.5K Cr ▲12.1% | ₹4.9K Cr ▲8.7% | ₹4.5K Cr ▲21.5% | ₹3.7K Cr ▲15.2% | ₹3.2K Cr ▲8.2% | ₹3.0K Cr ▲11.6% | ₹2.7K Cr ▲42.1% | ₹1.9K Cr |
| Assets | ||||||||||
| Fixed Assets | ₹2.8K Cr ▲16.1% | ₹2.4K Cr ▲15.7% | ₹2.1K Cr ▲9.7% | ₹1.9K Cr ▲24.0% | ₹1.5K Cr ▲15.7% | ₹1.3K Cr ▲10.6% | ₹1.2K Cr ▲27.5% | ₹944 Cr ▲21.5% | ₹777 Cr ▲20.7% | ₹644 Cr |
| CWIP | ₹702 Cr ▲59.5% | ₹440 Cr ▲61.8% | ₹272 Cr ▲13.8% | ₹239 Cr ▼32.9% | ₹356 Cr ▲49.0% | ₹239 Cr ▼18.7% | ₹294 Cr ▼40.7% | ₹496 Cr ▼3.7% | ₹515 Cr ▲92.9% | ₹267 Cr |
| Investments | ₹1 Cr ▼95.5% | ₹22 Cr ▲0.0% | ₹22 Cr ▲4.8% | ₹21 Cr ▲5.0% | ₹20 Cr ▲5.3% | ₹19 Cr ▲0.0% | ₹19 Cr ▼91.0% | ₹210 Cr ▲33.8% | ₹157 Cr ▲45.4% | ₹108 Cr |
| Other Assets | ₹3.4K Cr ▲2.8% | ₹3.3K Cr ▲7.2% | ₹3.1K Cr ▲13.8% | ₹2.7K Cr ▲5.3% | ₹2.6K Cr ▲22.2% | ₹2.1K Cr ▲24.4% | ₹1.7K Cr ▲28.5% | ₹1.3K Cr ▲8.7% | ₹1.2K Cr ▲42.3% | ₹859 Cr |
| Total Assets | ₹6.9K Cr ▲11.6% | ₹6.2K Cr ▲13.2% | ₹5.5K Cr ▲12.1% | ₹4.9K Cr ▲8.7% | ₹4.5K Cr ▲21.5% | ₹3.7K Cr ▲15.2% | ₹3.2K Cr ▲8.2% | ₹3.0K Cr ▲11.6% | ₹2.7K Cr ▲42.1% | ₹1.9K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹867 Cr ▲97.5% | ₹439 Cr ▼40.6% | ₹739 Cr ▲122.6% | ₹332 Cr ▼23.1% | ₹432 Cr ▼9.2% | ₹476 Cr ▲81.7% | ₹262 Cr ▲26300.0% | ₹-1 Cr ▼100.5% | ₹188 Cr ▲24.5% | ₹151 Cr |
| Investing CF | ₹-689 Cr ▼92.5% | ₹-358 Cr ▼86.5% | ₹-192 Cr ▲49.3% | ₹-379 Cr ▼36.8% | ₹-277 Cr ▼73.1% | ₹-160 Cr ▲40.7% | ₹-270 Cr ▲41.6% | ₹-462 Cr ▼41.7% | ₹-326 Cr ▼101.2% | ₹-162 Cr |
| Financing CF | ₹-93 Cr ▼1262.5% | ₹8 Cr ▲101.8% | ₹-440 Cr ▼331.6% | ₹190 Cr ▲163.5% | ₹-299 Cr ▼40.4% | ₹-213 Cr ▼1152.9% | ₹-17 Cr ▼103.2% | ₹529 Cr ▲844.6% | ₹56 Cr ▼34.9% | ₹86 Cr |
| Net Cash Flow | ₹85 Cr ▼5.6% | ₹90 Cr ▼15.9% | ₹107 Cr ▼25.2% | ₹143 Cr ▲199.3% | ₹-144 Cr ▼239.8% | ₹103 Cr ▲512.0% | ₹-25 Cr ▼137.9% | ₹66 Cr ▲180.5% | ₹-82 Cr ▼209.3% | ₹75 Cr |
| Free Cash Flow | ₹297 Cr ▲386.9% | ₹61 Cr ▼81.4% | ₹328 Cr ▲604.6% | ₹-65 Cr ▼140.4% | ₹161 Cr ▼44.9% | ₹292 Cr ▲1817.6% | ₹-17 Cr ▲96.2% | ₹-447 Cr ▼252.0% | ₹-127 Cr ▼1170.0% | ₹-10 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 77d ▼3.8% | 80d ▲3.9% | 77d ▼14.4% | 90d ▲4.7% | 86d ▼7.5% | 93d ▼13.9% | 108d ▼20.6% | 136d ▲25.9% | 108d ▲6.9% | 101d |
| Inventory Days | 284d ▲20.9% | 235d ▲29.1% | 182d ▼4.2% | 190d ▼7.3% | 205d ▲64.0% | 125d ▲11.6% | 112d ▼1.8% | 114d ▼21.4% | 145d ▲13.3% | 128d |
| Days Payable | 154d ▲14.1% | 135d ▲8.9% | 124d ▲0.0% | 124d ▼12.7% | 142d ▲39.2% | 102d ▲8.5% | 94d ▼16.1% | 112d ▼3.4% | 116d ▲27.5% | 91d |
| Cash Conv. Cycle | 207d ▲15.6% | 179d ▲32.6% | 135d ▼13.5% | 156d ▲4.0% | 150d ▲29.3% | 116d ▼7.9% | 126d ▼8.7% | 138d ▲0.7% | 137d ▼0.7% | 138d |
| Working Capital Days | 42d ▲20.0% | 35d ▼2.8% | 36d ▼18.2% | 44d ▼29.0% | 62d ▼1.6% | 63d ▲31.3% | 48d ▲14.3% | 42d ▲2200.0% | -2d ▼122.2% | 9d |
| ROCE | 15.0% ▲0.0% | 15.0% ▼21.1% | 19.0% ▲11.8% | 17.0% ▼32.0% | 25.0% ▲47.1% | 17.0% ▲13.3% | 15.0% ▲25.0% | 12.0% ▼33.3% | 18.0% ▼10.0% | 20.0% |
Source: Screener.in · Lower days = better efficiency
About Granules India Limited
Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Granules India Limited share price today?▾
Granules India Limited (GRANULES) is currently trading at ₹705.25 on NSE, up 0.01% as of the last market session. Prices update daily after market close on MarketNetra.
Is Granules India Limited available in F&O (Futures & Options)?▾
Yes, Granules India Limited (GRANULES) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Granules India Limited 52-week high and low?▾
Granules India Limited's 52-week high is ₹696 and the 52-week low is ₹431. The current price of ₹705.25 is -1.3% below the 52W high.
What is Granules India Limited P/E ratio?▾
Granules India Limited's current P/E ratio is 31.4. This indicates the market is paying ₹31.4 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Granules India Limited options?▾
Granules India Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade GRANULES options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.